Drug-Antibody Ratio of an Antibody-Drug Conjugate by SEC-MALS

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Drug-antibody ratio (DAR) is a critical attribute of antibody-drug conjugates (ADCs). DAR may often be determined quickly and effectively by combining SEC with three online detectors: MALS, UV, and dRI.
引用
收藏
页码:420 / 420
页数:1
相关论文
共 50 条
  • [41] Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serum
    Xu, Keyang
    Liu, Luna
    Dere, Randall
    Mai, Elaine
    Erickson, Rebecca
    Hendricks, Angela
    Lin, Kedan
    Junutula, Jagath R.
    Kaur, Surinder
    BIOANALYSIS, 2013, 5 (09) : 1057 - 1071
  • [42] A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates
    Wu, Gang
    Yu, Chuanfei
    Yin, Sicheng
    Du, Jialiang
    Zhang, Yifan
    Fu, Zhihao
    Wang, Lan
    Wang, Junzhi
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1241
  • [43] Antibody-drug conjugate and novel therapy in lung cancer
    Cho, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1310 - S1311
  • [44] Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
    Sheyi, Rotimi
    de la Torre, Beatriz G.
    Albericio, Fernando
    PHARMACEUTICS, 2022, 14 (02)
  • [45] Development of an antibody-drug conjugate with broad anticancer activity
    Lin, Siang-Yo
    Szekely, Zoltan
    Lin, Chen-Yong
    Bertino, Joseph R.
    Rather, Gulam Mohmad
    CANCER RESEARCH, 2017, 77
  • [46] Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
    Donnell, Andrew F.
    Zhang, Yong
    Stang, Erik M.
    Wei, Donna D.
    Tebben, Andrew J.
    Perez, Heidi L.
    Schroeder, Gretchen M.
    Pan, Chin
    Rao, Chetana
    Borzilleri, Robert M.
    Vite, Gregory D.
    Gangwar, Sanjeev
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5267 - 5271
  • [47] Lung cancer treatment with antibody-drug conjugate (ADC)
    Hotta, Katsuyuki
    CANCER SCIENCE, 2018, 109 : 818 - 818
  • [48] Antibody-Drug Conjugate (ADC) Research in Ophthalmology—a Review
    Jie Shen
    Mayssa Attar
    Pharmaceutical Research, 2015, 32 : 3572 - 3576
  • [49] Antibody-Drug Conjugate Payloads; Study of Auristatin Derivatives
    Akaiwa, Michinori
    Dugal-Tessier, Julien
    Mendelsohn, Brian A.
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 201 - 211
  • [50] Extracellular vesicles as modifiers of antibody-drug conjugate efficacy
    Barok, Mark
    Puhka, Maija
    Yazdi, Narjes
    Joensuu, Heikki
    JOURNAL OF EXTRACELLULAR VESICLES, 2021, 10 (04)